02 9541 3500Micropore HORIZON™: Scalable particle engineering from your lab to manufacturing
Micropore Technologies has announced the launch of its next-generation HORIZON™ systems, marking a significant advancement in automated, scalable particle engineering for formulation development and manufacturing.
Built on the company’s proven Advanced Crossflow (AXF) technology, the HORIZON™ platform addresses one of the industry’s most persistent challenges—seamlessly translating formulations from R&D to full-scale production. By enabling low-shear emulsification and precise, controlled particle formation, the system delivers highly reproducible and reliable results across a wide range of applications, including pharmaceuticals, CDMOs, and encapsulation processes.
The HORIZON™ range has been thoughtfully designed with scalability and efficiency in mind. From the compact HORIZON™ mini for development and pilot-scale work, to the industrial-scale HORIZON™ one, and the fully customisable HORIZON™ PRO, users can confidently scale processes without the need for extensive re-optimisation. Continuous processing, low holdup volumes, and sanitary design further enhance productivity by reducing downtime and simplifying cleaning between batches.
Early evaluations have demonstrated impressive performance, particularly in lipid nanoparticle (LNP) formulation. The system has shown the ability to produce consistent, monodispersed particles across varying volumes and lipid chemistries—highlighting its robustness and flexibility in demanding applications such as intracellular drug delivery.
At ATA Scientific, we see the HORIZON™ platform as a transformative solution for organisations seeking to accelerate development timelines while reducing scale-up risk and cost. By bridging the gap between laboratory innovation and commercial manufacturing, Micropore Technologies is setting a new benchmark for particle engineering.
Interested in how HORIZON™ can support your workflow? Contact ATA Scientific to learn more or request a demonstration.